NCT03598452View on ClinicalTrials.gov

High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

June 30, 2018

Conditions
Infection ViralUveitis, Posterior
Interventions
DRUG

Ganciclovir

Intravitreal Injection of Ganciclovir (IVG) was conducted in a week interval. The initial dose was 6mg/0.1ml at the first injection and it was reduced to 4.5mg/0.1ml at the second time; 3mg/0.1ml of IVG was maintained until the CMV could not be detected in aqueous humor.

All Listed Sponsors
lead

Aier School of Ophthalmology, Central South University

OTHER

NCT03598452 - High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients | Biotech Hunter | Biotech Hunter